Penn Medicine Partners With Cost Plus Drug Company to Bolster Access to Generic Drugs and Cut Their Costs

Penn Medicine is partnering with Mark Cuban’s Cost Plus Drug Company in order to “secure the top 100 most frequently dispensed generic drugs—such as antibiotics, cancer treatments, blood thinners, and asthma medications—from the company for the health system’s vast retail pharmacy network.”

The Cost Plus Marketplace was “developed to provide healthcare business purchasers with transparently priced medications.” Its aim is to eliminate certain mark-ups on common generic medications.

Penn Medicine pharmacies are “located inside all Penn Medicine hospitals and multi-specialty centers.” Cost Plus’s model will possibly help “ensure continued access” to medications during future shortages. Penn Medicine’s integrated pharmacy system also allows for “complete integration of drug information within patients’ electronic medical records and easy connectivity between providers and pharmacists who monitor for potential drug interactions.”

This large purchasing agreement will also “help decrease carbon emissions through less shipping and packaging waste.”